Please Wait
Applying Filters...
menu
    • menu
    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Lorlatinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,097Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Lorbrena

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Lorbrena

    Lorlatinib

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Lorbrena

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Lorlatinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 204

    2019 Revenue in Millions : 115

    Growth (%) : 77

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Lorbrena

    Lorlatinib

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Lorbrena

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Lorlatinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 266

    2020 Revenue in Millions : 204

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Lorbrena

    Lorlatinib

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Lorbrena

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Lorlatinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 343

    2021 Revenue in Millions : 266

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Lorbrena

    Lorlatinib

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Lorbrena

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Lorlatinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 539

    2022 Revenue in Millions : 343

    Growth (%) : 57

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Lorbrena

    Lorlatinib

    arrow
    APGA Annual Conference
    Not Confirmed

    Brand Name : Lorbrena

    U.S.A
    arrow
    APGA Annual Conference
    Not Confirmed

    Pfizer Inc.

    Lorlatinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 731

    2023 Revenue in Millions : 539

    Growth (%) : 36

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF